Congratulations, Advanced Industries Accelerator Grant Recipients

Colorado BioScience Association congratulates CBSA members awarded proof-of-concept and early-stage capital grants by Colorado’s Office of Economic Development and International Trade (OEDIT). A total of 27 start ups from Colorado’s designated Advanced Industries will receive $7.3 million in funding.

CBSA’s Policy + Advocacy team led the fight on behalf of Colorado’s Advanced Industries to preserve the Advanced Industries Accelerator Grant Program for the next fiscal year in the face of massive state budget shortfalls due to COVID-19. Capital + Growth is a top priority for our ecosystem. The CBSA team worked tirelessly behind the scenes to protect the program and mobilized our members to communicate the importance of the program, which is a critical source of non-dilutive funding for our life sciences companies.

CBSA members receiving grants from the current cycle are:

Allander Biotechnologies, LLC., Aurora, $250,000
Cliexa, Denver, $250,000
Crestone, Inc., Boulder, $250,000
Impressio, Inc., Aurora, $250,000
SiEC Biotechnologies, Fort Collins, $250,000
VitriVax, Inc., Boulder, $240,000
University of Colorado Denver, Researcher Maria Valeria Canto-Soler -Denver, $150,000
University of Colorado Boulder, Researcher Christopher Lowry-Boulder, $150,00
Cetya Therapeutics, Second Round or “transition” funding
Colorado School of Mines, Researcher Terry Lowe, Proof of Concept second round or “transition” funding

Congratulations to all grant recipients from Colorado’s innovation economy. CBSA applauds your success and is proud to support this vital program.

Reference the full company list.

Categories: CBSA News